ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment

NCT00331097 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: docetaxel
DRUG: cyclophosphamide
DRUG: methotrexate
DRUG: 5-fluorouracil

Sponsor

National Cancer Institute, Naples